Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorder

Epilepsy and Behavior

Volumn 31, Issue , 2014, Pages 267-275

  Pineda, Eduardo ^a   Jentsch, J David ^a   Shin, Don ^a   Griesbach, Grace ^a   Sankar, Raman ^a,b   Mazarati, Andrey ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA Children's Discovery and Innovation Institute   (United States)

Author keywords

Attention deficit hyperactivity disorder; Depression; Epilepsy; Lateralized reaction time task; Norepinephrine; Serotonin

Indexed keywords

NORADRENALIN; PILOCARPINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; EPILEPSY; EPILEPTIC STATE; FORCED SWIM TEST; FOREBRAIN; LOCUS CERULEUS; MALE; NONHUMAN; NORADRENERGIC SYSTEM; RAPHE NUCLEUS; RAT; REACTION TIME; WISTAR RAT;

5-HT; ADHD; ATTENTION DEFICIT/HYPERACTIVITY DISORDER; DEPRESSION; ELEVATED PLUS MAZE TEST; EPILEPSY; EPMT; FAST CYCLIC VOLTAMMETRY; FCV; FORCED SWIMMING TEST; FST; LATERALIZED REACTION-TIME TASK; LC; LOCUS COERULEUS; LRTT; NE; NOREPINEPHRINE; PFC; PREFRONTAL CORTEX; RAPHE NUCLEUS; RN; SE; SEROTONIN; STATUS EPILEPTICUS; TEMPORAL LOBE EPILEPSY; TLE;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIORAL SYMPTOMS; BRAIN; CHRONIC DISEASE; COMPULSIVE BEHAVIOR; CONVULSANTS; DISEASE MODELS, ANIMAL; EPILEPSY; FUNCTIONAL LATERALITY; IMMOBILITY RESPONSE, TONIC; LITHIUM CHLORIDE; MALE; PHOTIC STIMULATION; PILOCARPINE; RATS; RATS, WISTAR; REACTION TIME; SWIMMING;

EID: 84892994945     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.10.004     Document Type: Article

References (79)

1. Schubert R. Attention deficit disorder and epilepsy. Pediatr Neurol 2005, 32:1-10.
2. Parisi P., Moavero R., Verrotti A., Curatolo P. Attention deficit hyperactivity disorder in children with epilepsy. Brain Dev 2010, 32:10-16.
3. Kaufmann R., Goldberg-Stern H., Shuper A. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. J Child Neurol 2009, 24:727-733.
4. Kanner A.M. The use of psychotropic drugs in epilepsy: what every neurologist should know. Semin Neurol 2008, 28:379-388.
5. Hesdorffer D.C., Ludvigsson P., Olafsson E., Gudmundsson G., Kjartansson O., Hauser W.A. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004, 61:731-736.
6. Burd L., Kerbeshian J., Fisher W. Does the use of phenobarbital as an anticonvulsant permanently exacerbate hyperactivity?. Can J Psychiatry 1987, 32:10-13.
7. Meador K.J., Loring D.W., Huh K., Gallagher B.B., King D.W. Comparative cognitive effects of anticonvulsants. Neurology 1990, 40:391-394.
8. Lee D.O., Steingard R.J., Cesena M., Helmers S.L., Riviello J.J., Mikati M.A. Behavioral side effects of gabapentin in children. Epilepsia 1996, 37:87-90.
9. Besag F.M. Behavioural effects of the new anticonvulsants. Drug Saf 2001, 24:513-536.
10. Stores G., Williams P.L., Styles E., Zaiwalla Z. Psychological effects of sodium valproate and carbamazepine in epilepsy. Arch Dis Child 1992, 67:1330-1337.
11. Berg I., Butler A., Ellis M., Foster J. Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial. Dev Med Child Neurol 1993, 35:149-157.
12. Burton L.A., Harden C. Effect of topiramate on attention. Epilepsy Res 1997, 27:29-32.
13. Aldenkamp A.P., Baker G., Mulder O.G., Chadwick D., Cooper P., Doelman J., et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000, 41:1167-1178.
14. Sankar R., Mazarati A. Neurobiology of depression as a comorbidity of epilepsy. Jasper's basic mechanisms of the epilepsies 2012, New York: Oxford University Press, Bethesda (MD), pp. 945-958. 4th ed. J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.).
15. Pineda E., Shin D., Sankar R., Mazarati A.M. Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms. Epilepsia 2010, 51(Suppl. 3):110-114.
16. McIntyre D.C., Poulter M.O., Gilby K. Kindling: some old and some new. Epilepsy Res 2002, 50:79-92.
17. Dube C.M., Zhou J.L., Hamamura M., Zhao Q., Ring A., Abrahams J., et al. Cognitive dysfunction after experimental febrile seizures. Exp Neurol 2009, 215:167-177.
18. Kleen J.K., Sesque A., Wu E.X., Miller F.A., Hernan A.E., Holmes G.L., et al. Early-life seizures produce lasting alterations in the structure and function of the prefrontal cortex. Epilepsy Behav 2011, 22:214-219.
19. Lenck-Santini P.P., Holmes G.L. Altered phase precession and compression of temporal sequences by place cells in epileptic rats. J Neurosci 2008, 28:5053-5062.
20. Mazarati A., Siddarth P., Baldwin R.A., Shin D., Caplan R., Sankar R. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 2008, 131:2071-2083.
21. Mazarati A.M., Pineda E., Shin D., Tio D., Taylor A.N., Sankar R. Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol Dis 2010, 37:461-467.
22. Mazarati A.M., Shin D., Kwon Y.S., Bragin A., Pineda E., Tio D., et al. Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy. Neurobiol Dis 2009, 34:457-461.
23. Pineda E.A., Hensler J.G., Sankar R., Shin D., Burke T.F., Mazarati A.M. Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression. Neuropsychopharmacology 2011, 36:1305-1316.
24. Jentsch J.D. Genetic vasopressin deficiency facilitates performance of a lateralized reaction-time task: altered attention and motor processes. J Neurosci 2003, 23:1066-1071.
25. Jentsch J.D. Impaired visuospatial divided attention in the spontaneously hypertensive rat. Behav Brain Res 2005, 157:323-330.
26. Jentsch J.D., Aarde S.M., Seu E. Effects of atomoxetine and methylphenidate on performance of a lateralized reaction time task in rats. Psychopharmacology (Berl) 2009, 202:497-504.
27. Del Campo N., Chamberlain S.R., Sahakian B.J., Robbins T.W. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 2011, 69:e145-e157.
28. Mefford I.N., Potter W.Z. A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation. Med Hypotheses 1989, 29:33-42.
29. Pliszka S.R., McCracken J.T., Maas J.W. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996, 35:264-272.
30. Arnsten A.F. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 1997, 11:151-162.
31. Elhwuegi A.S. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:435-451.
32. Nutt D.J. The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psychopharmacol 2002, 17(Suppl. 1):S1-S12.
33. Ordway G.A., Schenk J., Stockmeier C.A., May W., Klimek V. Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression. Biol Psychiatry 2003, 53:315-323.
34. Ordway G.A., Smith K.S., Haycock J.W. Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J Neurochem 1994, 62:680-685.
35. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
36. Overstreet D.H., Friedman E., Mathe A.A., Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 2005, 29:739-759.
37. Pucilowski O., Overstreet D.H. Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains. Brain Res Bull 1993, 32:471-475.
38. Zangen A., Nakash R., Overstreet D.H., Yadid G. Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology (Berl) 2001, 155:434-439.
39. Pineda E.A., Hensler J.G., Sankar R., Shin D., Burke T.F., Mazarati A.M. Interleukin-1beta causes fluoxetine resistance in an animal model of epilepsy-associated depression. Neurotherapeutics 2012, 9:477-485.
40. Wrona M.Z., Dryhurst G. Oxidation chemistry of 5-hydroxytryptamine. 1. Mechanism and products formed at micromolar concentrations. J Org Chem 1987, 52:2817-2825.
41. Callado L.F., Meana J.J., Grijalba B., Pazos A., Sastre M., Garcia-Sevilla J.A. Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. J Neurochem 1998, 70:1114-1123.
42. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, San Diego.
43. Callado L.F., Stamford J.A. Alpha2A- but not alpha2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus: voltammetric data. Eur J Pharmacol 1999, 366:35-39.
44. Herr N.R., Park J., McElligott Z.A., Belle A.M., Carelli R.M., Wightman R.M. In vivo voltammetry monitoring of electrically evoked extracellular norepinephrine in subregions of the bed nucleus of the stria terminalis. J Neurophysiol 2012, 107:1731-1737.
45. Iravani M.M., Kruk Z.L. Real-time measurement of stimulated 5-hydroxytryptamine release in rat substantia nigra pars reticulata brain slices. Synapse 1997, 25:93-102.
46. Jackson B.P., Dietz S.M., Wightman R.M. Fast-scan cyclic voltammetry of 5-hydroxytryptamine. Anal Chem 1995, 67:1115-1120.
47. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 2000, 24:31-39.
48. Marescaux C., Vergnes M., Depaulis A. Genetic absence epilepsy in rats from Strasbourg-a review. J Neural Transm Suppl 1992, 35:37-69.
49. Sankar R., Shin D.H., Liu H., Mazarati A., Pereira de Vasconcelos A., Wasterlain C.G. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 1998, 18:8382-8393.
50. Goffin K., Nissinen J., Van Laere K., Pitkanen A. Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat. Exp Neurol 2007, 205:501-505.
51. Arida R.M., Scorza F.A., Peres C.A., Cavalheiro E.A. The course of untreated seizures in the pilocarpine model of epilepsy. Epilepsy Res 1999, 34:99-107.
52. McIntyre D.C., Gilby K.L. Genetically seizure-prone or seizure-resistant phenotypes and their associated behavioral comorbidities. Epilepsia 2007, 48(Suppl. 9):30-32.
53. Anisman H., McIntyre D.C. Conceptual, spatial, and cue learning in the Morris water maze in fast or slow kindling rats: attention deficit comorbidity. J Neurosci 2002, 22:7809-7817.
54. Mazarati A., Shin D., Auvin S., Caplan R., Sankar R. Kindling epileptogenesis in immature rats leads to persistent depressive behavior. Epilepsy Behav 2007, 10:377-383.
55. Cavalheiro E.A., Naffah-Mazzacoratti M.G., Mello L.E., Leite J.P. The pilocarpine model of seizures. Models of seizures and epilepsy 2006, 433-448. Elsevier, Amsterdam. A. Pitkanen, P.A. Schwartzkroin, S.L. Moshe (Eds.).
56. Faure J.B., Akimana G., Carneiro J.E., Cosquer B., Ferrandon A., Geiger K., et al. A comprehensive behavioral evaluation in the lithium-pilocarpine model in rats: effects of carisbamate administration during status epilepticus. Epilepsia 2013, 54:1203-1213.
57. Sankar R., Shin D., Liu H., Wasterlain C., Mazarati A. Epileptogenesis during development: injury, circuit recruitment, and plasticity. Epilepsia 2002, 43(Suppl. 5):47-53.
58. Sankar R., Shin D., Mazarati A.M., Liu H., Katsumori H., Lezama R., et al. Epileptogenesis after status epilepticus reflects age- and model-dependent plasticity. Ann Neurol 2000, 48:580-589.
59. Ferreira B.L., Valle A.C., Cavalheiro E.A., Timo-Iaria C. Absence-like seizures in adult rats following pilocarpine-induced status epilepticus early in life. Braz J Med Biol Res 2003, 36:1685-1694.
60. Freitas R.M., Sousa F.C., Vasconcelos S.M., Viana G.S., Fonteles M.M. Pilocarpine-induced status epilepticus in rats: lipid peroxidation level, nitrite formation, GABAergic and glutamatergic receptor alterations in the hippocampus, striatum and frontal cortex. Pharmacol Biochem Behav 2004, 78:327-332.
61. Hirotsu C., Matos G., Tufik S., Andersen M.L. Changes in gene expression in the frontal cortex of rats with pilocarpine-induced status epilepticus after sleep deprivation. Epilepsy Behav 2013, 27:378-384.
62. Junior H.V., de Franca Fonteles M.M., Mendes de Freitas R. Acute seizure activity promotes lipid peroxidation, increased nitrite levels and adaptive pathways against oxidative stress in the frontal cortex and striatum. Oxid Med Cell Longev 2009, 2:130-137.
63. Tejada S., Gonzalez J.J., Rial R.V., Coenen A.M., Gamundi A., Esteban S. Electroencephalogram functional connectivity between rat hippocampus and cortex after pilocarpine treatment. Neuroscience 2010, 165:621-631.
64. Altshuler L., Rausch R., Delrahim S., Kay J., Crandall P. Temporal lobe epilepsy, temporal lobectomy, and major depression. J Neuropsychiatry Clin Neurosci 1999, 11:436-443.
65. Kanner A.M. Epilepsy, suicidal behaviour, and depression: do they share common pathogenic mechanisms?. Lancet Neurol 2006, 5:107-108.
66. Kondziella D., Alvestad S., Vaaler A., Sonnewald U. Which clinical and experimental data link temporal lobe epilepsy with depression?. J Neurochem 2007, 103:2136-2152.
67. Sankar R., Shin D.H., Wasterlain C.G. Serum neuron-specific enolase is a marker for neuronal damage following status epilepticus in the rat. Epilepsy Res 1997, 28:129-136.
68. Kubova H., Druga R., Haugvicova R., Suchomelova L., Pitkanen A. Dynamic changes of status epilepticus-induced neuronal degeneration in the mediodorsal nucleus of the thalamus during postnatal development of the rat. Epilepsia 2002, 43(Suppl. 5):54-60.
69. Kubova H., Druga R., Lukasiuk K., Suchomelova L., Haugvicova R., Jirmanova I., et al. Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats. J Neurosci 2001, 21:3593-3599.
70. Chandley M.J., Ordway G.A. Noradrenergic dysfunction in depression and suicide. The neurobiological basis of suicide 2012, CRC Press, Boca Raton (FL), pp. 29-64. Y. Dwivedi (Ed.).
71. Minzenberg M.J. Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits. Neurotherapeutics 2012, 9:610-621.
72. Winstanley C.A. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol 2011, 164:1301-1321.
73. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 1989, 290:213-242.
74. Shipley M.T., Fu L., Ennis M., Liu W.L., Aston-Jones G. Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. J Comp Neurol 1996, 365:56-68.
75. Jodo E., Chiang C., Aston-Jones G. Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience 1998, 83:63-79.
76. Sara S.J., Herve-Minvielle A. Inhibitory influence of frontal cortex on locus coeruleus neurons. Proc Natl Acad Sci U S A 1995, 92:6032-6036.
77. McIntosh D., Kutcher S., Binder C., Levitt A., Fallu A., Rosenbluth M. Adult ADHD and comorbid depression: a consensus-derived diagnostic algorithm for ADHD. Neuropsychiatr Dis Treat 2009, 5:137-150.
78. Daviss W.B. A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment. J Child Adolesc Psychopharmacol 2008, 18:565-571.
79. Detour J., Schroeder H., Desor D., Nehlig A. A 5-month period of epilepsy impairs spatial memory, decreases anxiety, but spares object recognition in the lithium-pilocarpine model in adult rats. Epilepsia 2005, 46:499-508.